2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $15B | $15B | $16B | $18B | $19B |
Cost of Revenue | $8.4B | $8.6B | $9.5B | $10B | $10B |
Gross Profit | $6.1B | $6.4B | $7B | $8.1B | $8.7B |
Gross Profit % | 42% | 42% | 43% | 45% | 45% |
R&D Expenses | $674M | $717M | $799M | $845M | $956M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $2.5B | $2.6B | $2.9B | $3.4B | $3.8B |
Dep. & Amort. | $480M | $511M | $515M | $549M | $562M |
Def. Tax | $26M | -$251M | $37M | -$80M | -$37M |
Stock Comp. | $131M | $175M | $202M | $220M | $244M |
Chg. in WC | -$1.1B | -$937M | -$1.6B | -$939M | -$1.4B |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $1.9B | $2.6B | $1.4B | $2.1B | $2.9B |
ST Investments | $0 | $0 | $33M | $15M | $0 |
Cash & ST Inv. | $1.9B | $2.6B | $1.5B | $2.1B | $2.9B |
Receivables | $2.4B | $2.7B | $3.2B | $3B | $3.4B |
Inventory | $0 | $0 | $0 | $0 | $0 |